Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis

被引：0
|
作者：
Kenan Aksu
Ayhan Donmez
Yesim Ertan
Gokhan Keser
Vedat Inal
Gonca Oder
Murat Tombuloglu
Yasemin Kabasakal
Eker Doganavsargil
机构：
[1] Ege University School of Medicine Hospital,Internal Medicine
[2] Ege University School of Medicine Hospital,Rheumatology Division
[3] Ege University School of Medicine Hospital,Internal Medicine
来源：
Rheumatology International | 2007年 / 28卷
关键词：
Hodgkin’s lymphoma; Etanercept; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
It has been well known that anti-TNF drugs might increase lymphoma risk in rheumatoid arthritis (RA), where the rate of lymphoma has already been increased. However, unlike RA, an increased rate of lymphoma has not been reported in ankylosing spondylitis (AS). Hereby, we present a case with AS developing Hodgkin’s lymphoma (HL) following 6 months of etanercept treatment. Pathological analysis revealed mixed cellular type of HL. Although we report a single case, it should be kept in mind that anti-TNF drugs might cause lymphoma development not only in RA, but also in AS.
引用
收藏
相关论文
共 50 条
  • [41] ANKYLOSING SPONDYLITIS AND FOLLICULAR LYMPHOMA
    Cuttell, Joanna
    Bukhari, Marwan
    Heath, Joseph
    RHEUMATOLOGY, 2015, 54 : 180 - 180
  • [42] Refractory Takayasu's arteritis treated successfully with etanercept in a patient with ankylosing spondylitis
    Abhishek, A.
    Courtney, P.
    RHEUMATOLOGY, 2007, 46 : I67 - I67
  • [43] The effects of etanercept on the functional status of subjects with ankylosing spondylitis
    van der Heijde, DM
    Woolley, JM
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 243 - 244
  • [44] Unusual occurrence of avascular necrosis with bilateral involvement and ankylosing spondylitis, meningioma and Hodgkin lymphoma
    Stoicanescu, Livia Dorina
    Cevei, Mariana Lidia
    Sirbu, Elena Maria
    Zdrinca, Mihaela Mirela
    Mutiu, Gabriela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (03): : 1003 - 1007
  • [45] Etanercept in adult patients with early onset ankylosing spondylitis
    Inman, Robert D.
    Clegg, Daniel O.
    Davis, John C.
    Whitmore, James B.
    Solinger, Alan
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (08) : 1634 - 1636
  • [46] Late sequelae and survivorship following treatment of Hodgkin's lymphoma
    Behringer, K.
    Halbsguth, T. V.
    Borchmann, P.
    ONKOLOGE, 2014, 20 (05): : 470 - 476
  • [47] New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate
    Davis, JC
    Huang, F
    Maksymowych, W
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (03) : 481 - +
  • [48] One-year efficacy of etanercept in ankylosing spondylitis
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, JJ
    Clegg, DO
    Kivitz, AJ
    Inman, RD
    Solinger, A
    Whitmore, J
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 390 - 390
  • [49] Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report
    Erdem, Yasemin
    Altunay, Ilknur Kivanc
    Ozkur, Ezgi
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [50] Reintroduction of Etanercept During Treatment of Cutaneous Mycobacterium marinum Infection in a Patient With Ankylosing Spondylitis
    Dare, Jason A.
    Jahan, Shormi
    Hiatt, Kim
    Torralba, Karina D.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05): : 583 - 586
12345